HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Blanca Boluda Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

5/2023Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.
6/2022Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia.
4/2022Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study.
1/2022No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.
6/2021A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
1/2021Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
1/2021Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
1/2020Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy.
9/2019Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
5/2018A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Blanca Boluda Research Topics

Disease

13Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2023 - 01/2017
2Febrile Neutropenia
10/2023 - 03/2020
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 09/2018
2Graft vs Host Disease (Graft-Versus-Host Disease)
08/2021 - 11/2014
2Mycoses (Diseases, Fungus)
09/2019 - 07/2015
2Acute Promyelocytic Leukemia
01/2019 - 01/2019
1Leukemia
10/2023
1Cardiovascular Diseases (Cardiovascular Disease)
04/2023
1Neoplasms (Cancer)
01/2022
1Pneumonia (Pneumonitis)
08/2021
1Respiratory Insufficiency (Respiratory Failure)
08/2021
1Sepsis (Septicemia)
08/2021
1Aspergillosis
03/2020
1Disease Progression
03/2020
1Philadelphia Chromosome
06/2019
1Cardiomyopathies (Cardiomyopathy)
07/2017
1Heart Failure
07/2017
1Multiple Myeloma
02/2015
1Hematologic Neoplasms (Hematological Malignancy)
11/2014

Drug/Important Bio-Agent (IBA)

4AnthracyclinesIBA
01/2021 - 07/2017
3Cytarabine (Cytosar-U)FDA LinkGeneric
05/2018 - 12/2017
3Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
05/2018 - 07/2017
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2019 - 07/2017
2fludarabineIBA
05/2018 - 01/2018
2plerixaforFDA Link
05/2018 - 01/2018
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2018 - 01/2018
1FosfomycinFDA Link
10/2023
1Ciprofloxacin (Cipro)FDA LinkGeneric
10/2023
1fms-Like Tyrosine Kinase 3IBA
06/2022
1Tyrosine Kinase InhibitorsIBA
06/2022
1Monoclonal AntibodiesIBA
01/2022
1Gemtuzumab (Mylotarg)FDA Link
01/2022
1CalicheamicinsIBA
01/2022
1SteroidsIBA
08/2021
1selinexorIBA
06/2021
1AzolesIBA
03/2020
1quizartinibIBA
03/2020
1CopperIBA
09/2018
1Cytidine Monophosphate (CMP)IBA
07/2017
1Antifungal AgentsIBA
07/2015
1AnidulafunginFDA Link
07/2015
1Bortezomib (Velcade)FDA Link
02/2015
1Melphalan (Alkeran)FDA LinkGeneric
02/2015
1Busulfan (Busulfex)FDA Link
02/2015

Therapy/Procedure

6Drug Therapy (Chemotherapy)
05/2023 - 01/2019
4Therapeutics
04/2023 - 02/2015
4Induction Chemotherapy
04/2022 - 01/2017
2Salvage Therapy
06/2021 - 06/2019
1Radiotherapy
01/2022
1Photopheresis
08/2021
1Parenteral Nutrition
08/2021
1Transplantation
11/2014